Searching... Searching...
  • NVP -1.26%
  • Köp 1.39
  • Sälj 1.40
  • Senast 1.41
  • SEK

  • NEVPF +NA
  • Buy NA
  • Sell NA
  • Latest NA
  • USD

Newsletters

September

NeuroVive's interim CEO Jan Nilsson looks ahead

Read More

August

Eskil Elmér comments on CIRCUS trial study results

Read More

July

Video interview with NeuroVive's Chairman

Read More

June additional newsletter

Q & A on topline result from the CIRCUS study

Read More

June – 2015

Shareholder event in Lund: Focus on NeuroVive's project portfolio

Read More

May additional newsletter 2

NeuroVive raises SEK 70 million, from institutional investors in the US

Read More

May additional newsletter

Questions and answers in connection with tonight's press release, 7 May

Read More

May

NeuroVive signs strategic agreement with Sanofi

Read More

April

Clinical phase II study with NeuroSTAT® passes safety evaluation

Read More

March

Research paper on the methodology of the CIRCUS study

Read More

February

An eventful start to the year

Read More

January

Interview with researcher Magnus Hansson about NeuroVive’s focus on kidney injury

Read More